GO Term | Evidence Code | PMID |
---|---|---|
negative regulation of membrane potential | ||
negative regulation of heterotypic cell-cell adhesion | ||
acute-phase response | ||
response to glucocorticoid | ||
insulin secretion |
GO Term | Evidence Code | PMID |
---|---|---|
extracellular space | ||
extracellular region | ||
centrosome | ||
nucleoplasm | ||
cytosol |
GO Term | Evidence Code | PMID |
---|---|---|
interleukin-1, type I receptor binding | ||
interleukin-1 receptor antagonist activity | ||
interleukin-1 type I receptor antagonist activity | ||
interleukin-1, type II receptor binding | ||
interleukin-1 type II receptor antagonist activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:14115 | toxic shock syndrome | |
DOID:1485 | cystic fibrosis | |
DOID:1532 | pleural disease | |
DOID:1596 | depressive disorder | |
DOID:178 | vascular disease | |
DOID:1909 | melanoma | |
DOID:224 | transient cerebral ischemia | |
DOID:2799 | bronchiolitis obliterans | |
DOID:2841 | asthma | |
DOID:285 | hairy cell leukemia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025